Bank of America’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-25,000
Closed -$2.49M 7078
2018
Q3
$2.49M Hold
25,000
﹤0.01% 3813
2018
Q2
$1.78M Buy
25,000
+5,000
+25% +$419K ﹤0.01% 4063
2018
Q1
$2.08M Buy
+20,000
New +$2.25M ﹤0.01% 3852

Other funds holding ANAB

Bank of America's ANAB Position: Q1 2026 in Review

Bank of America increased its AnaptysBio (ANAB) stake by 283% in Q1 2026, buying an estimated $19.9M and bringing the position to 501,086 shares worth $27.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2108.

Bank of America first reported a position in ANAB in Q1 2017 and has held it in 37 quarters since. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • Bank of America held 501,086 shares of AnaptysBio worth $27.8M as of Q1 2026.
  • Bank of America bought 370,319 AnaptysBio shares in Q1 2026, an estimated $19.9M.
  • AnaptysBio made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2108 holding.
  • Bank of America first reported a position in AnaptysBio in Q1 2017 and has held it in 37 quarters since.
  • 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.